InMed Pharmaceuticals Inc. (INM) Financials

INM Assets vs Liabilities
DateAssetsLiabilities
Sept. 30, 2024 10.5 billion 2.1 billion
June 30, 2024 11.8 million 2.6 million
March 31, 2024 13.4 million 2.3 million
Dec. 31, 2023 15.3 million 2.5 million

INM Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Sept. 30, 2024 -1.8 billion 29.0 million
June 30, 2024 -1.0 million 38954
March 31, 2024 -2.0 million 55305
Dec. 31, 2023 -1.9 million 18264

INM Net Income

No data available :(

INM Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Sept. 30, 2024 5.6 billion 633.8 million -
June 30, 2024 6.6 million 644865 962662
March 31, 2024 7.6 million 725236 1.1 million
Dec. 31, 2023 9.5 million 802784 1.2 million

INM Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Sept. 30, 2024 620.1 million
June 30, 2024 7.6 billion
March 31, 2024 9.6 million
Dec. 31, 2023 8.0 million

INM Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Sept. 30, 2024 - 771.2 million 1.4 billion -
June 30, 2024 9291 1.2 million 1.2 million 1.4 billion
March 31, 2024 71 656764 1.3 million -1.4 billion
Dec. 31, 2023 9219 609791 1.4 million -

INM Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Sept. 30, 2024 2.0 billion 1.5 billion
June 30, 2024 1.3 million 7.0 billion
March 31, 2024 1.2 million 1.0 million
Dec. 31, 2023 1.2 million 916058

INM

Price: $1.49

52 week price:
0.58
5.50

Earnings Per Share: -6.09 USD

P/E Ratio: -0.14

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: Canada

Volume: 53653

Market Capitalization: 2.8 million

Links: